CA Stock MarketDetailed Quotes

ATE Antibe Therapeutics Inc

Watchlist
  • 0.295
  • 0.0000.00%
15min DelayMarket Closed Apr 10 09:30 ET
15.64MMarket Cap-842P/E (TTM)

Antibe Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(FY)Mar 31, 2022
(FY)Mar 31, 2021
(FY)Mar 31, 2020
(FY)Mar 31, 2019
Total revenue
0
0
0
0
0
0
0
0
1.33%9.67M
12.09%9.54M
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
1.33%9.67M
12.09%9.54M
Cost of revenue
-0.32%5.97M
16.63%5.99M
Gross profit
4.11%3.7M
5.18%3.55M
Operating expense
-1.42%4.6M
5.45M
6.28M
-19.52%20.55M
3.58M
4.66M
8.50%25.53M
11.88%23.53M
33.64%21.03M
56.75%15.74M
Selling and administrative expenses
-5.68%2.29M
--1.96M
--2.71M
-17.30%9.24M
--2.19M
--2.43M
10.57%11.17M
-18.41%10.1M
8.83%12.38M
64.43%11.38M
-Selling and marketing expense
20.90%81K
--96K
--147K
59.13%331K
--56K
--67K
80.87%208K
-96.95%115K
7.13%3.77M
4.13%3.52M
-General and administrative expense
-6.43%2.21M
--1.86M
--2.57M
-18.75%8.91M
--2.14M
--2.36M
9.76%10.96M
15.99%9.99M
9.60%8.61M
122.04%7.86M
Research and development costs
3.23%2.3M
--3.49M
--3.57M
-21.24%11.31M
--1.39M
--2.23M
6.93%14.36M
66.24%13.43M
104.84%8.08M
43.78%3.94M
Depreciation amortization depletion
----
----
----
----
----
----
----
----
37.26%571K
10.30%416K
-Depreciation and amortization
----
----
----
----
----
----
----
----
37.26%571K
10.30%416K
Operating profit
1.42%-4.6M
-5.45M
-6.28M
19.52%-20.55M
-3.58M
-4.66M
-8.50%-25.53M
-35.74%-23.53M
-42.24%-17.34M
-82.87%-12.19M
Net non-operating interest income (expenses)
-15.54%386K
462K
482K
390.88%1.35M
353K
457K
621.05%274K
109.48%38K
-0.50%-401K
65.62%-399K
Non-operating interest income
-15.47%388K
--464K
--484K
379.79%1.35M
--354K
--459K
513.04%282K
-53.54%46K
219.35%99K
78.71%31K
Non-operating interest expense
0.00%2K
--2K
--2K
0.00%8K
--1K
--2K
0.00%8K
-98.40%8K
16.28%500K
-63.50%430K
Other net income (expenses)
-3K
-19K
12K
-1,900.00%-90K
-7K
101.39%5K
72.60%-360K
-1,283.16%-1.31M
-179.07%-95K
Gain on sale of security
---3K
---19K
--12K
-1,900.00%-90K
---7K
----
-94.57%5K
396.77%92K
67.37%-31K
-179.07%-95K
Special income (charges)
----
----
----
----
----
----
----
64.77%-452K
---1.28M
--0
-Less:Impairment of capital assets
----
----
----
----
----
----
----
----
--1.28M
--0
-Less:Write off
----
----
----
----
----
----
----
--452K
--0
----
Income before tax
-0.19%-4.21M
-5.01M
-5.79M
23.60%-19.29M
-3.24M
-4.21M
-5.86%-25.25M
-25.21%-23.85M
-50.22%-19.05M
-64.59%-12.68M
Income tax
0
-99.26%1K
149.13%135K
Earnings from equity interest net of tax
Net income
2.39%-4.21M
-5.01M
-5.79M
22.29%-19.48M
-3.55M
-4.32M
4.72%-25.06M
-35.97%-26.3M
-50.93%-19.34M
-72.49%-12.82M
Net income continuous operations
-0.19%-4.21M
---5.01M
---5.79M
23.60%-19.29M
---3.24M
---4.21M
-5.86%-25.25M
-25.21%-23.85M
-48.65%-19.05M
-72.49%-12.82M
Net income discontinuous operations
--0
--0
--0
-196.84%-184K
---312K
---111K
107.76%190K
-738.36%-2.45M
---292K
----
Noncontrolling interests
Net income attributable to the company
2.39%-4.21M
-5.01M
-5.79M
22.29%-19.48M
-3.55M
-4.32M
4.72%-25.06M
-35.97%-26.3M
-50.93%-19.34M
-72.49%-12.82M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
2.39%-4.21M
-5.01M
-5.79M
22.29%-19.48M
-3.55M
-4.32M
4.72%-25.06M
-35.97%-26.3M
-50.93%-19.34M
-72.49%-12.82M
Diluted earnings per share
0.00%-0.08
-0.1
-0.11
26.00%-0.37
-0.06
-0.08
28.57%-0.5
1.41%-0.7
-18.33%-0.71
-20.00%-0.6
Basic earnings per share
0.00%-0.08
-0.1
-0.11
26.00%-0.37
-0.06
-0.08
28.57%-0.5
1.41%-0.7
-18.33%-0.71
-20.00%-0.6
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(FY)Mar 31, 2022(FY)Mar 31, 2021(FY)Mar 31, 2020(FY)Mar 31, 2019
Total revenue 000000001.33%9.67M12.09%9.54M
Operating revenue --0--0--0--0--0--0--0--01.33%9.67M12.09%9.54M
Cost of revenue -0.32%5.97M16.63%5.99M
Gross profit 4.11%3.7M5.18%3.55M
Operating expense -1.42%4.6M5.45M6.28M-19.52%20.55M3.58M4.66M8.50%25.53M11.88%23.53M33.64%21.03M56.75%15.74M
Selling and administrative expenses -5.68%2.29M--1.96M--2.71M-17.30%9.24M--2.19M--2.43M10.57%11.17M-18.41%10.1M8.83%12.38M64.43%11.38M
-Selling and marketing expense 20.90%81K--96K--147K59.13%331K--56K--67K80.87%208K-96.95%115K7.13%3.77M4.13%3.52M
-General and administrative expense -6.43%2.21M--1.86M--2.57M-18.75%8.91M--2.14M--2.36M9.76%10.96M15.99%9.99M9.60%8.61M122.04%7.86M
Research and development costs 3.23%2.3M--3.49M--3.57M-21.24%11.31M--1.39M--2.23M6.93%14.36M66.24%13.43M104.84%8.08M43.78%3.94M
Depreciation amortization depletion --------------------------------37.26%571K10.30%416K
-Depreciation and amortization --------------------------------37.26%571K10.30%416K
Operating profit 1.42%-4.6M-5.45M-6.28M19.52%-20.55M-3.58M-4.66M-8.50%-25.53M-35.74%-23.53M-42.24%-17.34M-82.87%-12.19M
Net non-operating interest income (expenses) -15.54%386K462K482K390.88%1.35M353K457K621.05%274K109.48%38K-0.50%-401K65.62%-399K
Non-operating interest income -15.47%388K--464K--484K379.79%1.35M--354K--459K513.04%282K-53.54%46K219.35%99K78.71%31K
Non-operating interest expense 0.00%2K--2K--2K0.00%8K--1K--2K0.00%8K-98.40%8K16.28%500K-63.50%430K
Other net income (expenses) -3K-19K12K-1,900.00%-90K-7K101.39%5K72.60%-360K-1,283.16%-1.31M-179.07%-95K
Gain on sale of security ---3K---19K--12K-1,900.00%-90K---7K-----94.57%5K396.77%92K67.37%-31K-179.07%-95K
Special income (charges) ----------------------------64.77%-452K---1.28M--0
-Less:Impairment of capital assets ----------------------------------1.28M--0
-Less:Write off ------------------------------452K--0----
Income before tax -0.19%-4.21M-5.01M-5.79M23.60%-19.29M-3.24M-4.21M-5.86%-25.25M-25.21%-23.85M-50.22%-19.05M-64.59%-12.68M
Income tax 0-99.26%1K149.13%135K
Earnings from equity interest net of tax
Net income 2.39%-4.21M-5.01M-5.79M22.29%-19.48M-3.55M-4.32M4.72%-25.06M-35.97%-26.3M-50.93%-19.34M-72.49%-12.82M
Net income continuous operations -0.19%-4.21M---5.01M---5.79M23.60%-19.29M---3.24M---4.21M-5.86%-25.25M-25.21%-23.85M-48.65%-19.05M-72.49%-12.82M
Net income discontinuous operations --0--0--0-196.84%-184K---312K---111K107.76%190K-738.36%-2.45M---292K----
Noncontrolling interests
Net income attributable to the company 2.39%-4.21M-5.01M-5.79M22.29%-19.48M-3.55M-4.32M4.72%-25.06M-35.97%-26.3M-50.93%-19.34M-72.49%-12.82M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 2.39%-4.21M-5.01M-5.79M22.29%-19.48M-3.55M-4.32M4.72%-25.06M-35.97%-26.3M-50.93%-19.34M-72.49%-12.82M
Diluted earnings per share 0.00%-0.08-0.1-0.1126.00%-0.37-0.06-0.0828.57%-0.51.41%-0.7-18.33%-0.71-20.00%-0.6
Basic earnings per share 0.00%-0.08-0.1-0.1126.00%-0.37-0.06-0.0828.57%-0.51.41%-0.7-18.33%-0.71-20.00%-0.6
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data